Case Study: an emerging pharmaceutical company achieves 60% lower cost per prescription with StackAdapt

emerging pharmaceutical company cuts cost per script by 60% with StackAdapt

An emerging pharmaceutical company faced the challenge of launching an FDA-approved treatment with a limited budget, minimal brand recognition, and a lean team. To build awareness and connect media investment to prescriptions, they partnered with StackAdapt to develop a programmatic advertising strategy.

StackAdapt implemented a multi-channel campaign using CTV, video, display, and native ads, alongside NPI targeting for doctors. Their solution included advanced measurement through lift studies and cross-channel attribution. The results included a 177% relative lift in brand awareness and a 60% reduction in cost per new prescription, turning the launch into a success.